Neurodevelopmental Abnormality
0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Sharp TherapeuticsPA - Pittsburgh
2 programsRandomized to Umbilical Cord Milking at birthN/A
Umbilical Cord MilkingN/A1 trial
Active Trials
Cook MedicalIN - Bloomington
1 programRandomized to Umbilical Cord Milking at birthN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Cook MedicalRandomized to Umbilical Cord Milking at birth
Sharp TherapeuticsUmbilical Cord Milking
Clinical Trials (2)
Total enrollment: 2,407 patients across 2 trials
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
Start: Jul 2019Est. completion: Dec 20241,200 patients
N/AUnknown
Umbilical Cord Milking in Non-Vigorous Infants Developmental Followup (MINVIFU)
Start: Jan 2019Est. completion: Sep 20231,207 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.